Abstract:Purpose Gastric carcinogenesis is a multistep process and is the second-highest cause of cancer death worldwide with a high incidence of invasion and metastasis. MicroRNAs (miRNAs) engage in complex interactions with the machinery that controls the transcriptome and concurrently target multiple mRNAs. Recent evidence has shown that miRNAs are involved in the cancer progression, including promoting cell-cycle, conferring resistance to apoptosis, and enhancing invasiveness and metastasis. Here, we aim to elucidate the roles of miRNAs, especially microRNA-4665-3p (miR-4665-3p), in the inhibitory effect of arsenic sulfide in gastric cancer (GC). Methods The arsenic sulfide-induced miRNA expression alterations in AGS cells was determined by miRNA microarray. RT-PCR was used to further verify the arsenic sulfide-regulated miRNAs in GC tissues. The inhibition of miR-4665-3p on the migration and invasion of GC cells were determined by wound healing assay and transwell assay. Western blot analysis was used to detect the expression of EMT related proteins and the putative target of miR-4665-3p. Results The miR-4665-3p was up-regulated by arsenic sulfide and showed inhibition upon the migration and invasion of GC cells. MiRBase and Western blotting indicated that miR-4665-3p directly down-regulated the oncoprotein GSE1. Morphological observation also indicated that the up-regulation of miR-4665-3p inhibits the EMT in GC cells. Conclusion Our data demonstrates that the increased expression of miR-4665-3p induced by arsenic sulfide suppresses the cell invasion, metastasis and EMT of GC cells, and has the potential to be a novel therapeutic target in GC.

Arsenic resistance protein 2 and microRNA biogenesis: Biological implications in cancer development

Molecular Mechanisms and Clinical Applications of Mir-22 in Regulating Malignant Progression in Human Cancer (Review)

Mir-22 Has a Potent Anti-Tumour Role with Therapeutic Potential in Acute Myeloid Leukaemia

Depletion of Ars2 inhibits cell proliferation and leukemogenesis in acute myeloid leukemia by modulating the miR-6734-3p/p27 axis

MicroRNA-191, Regulated by HIF-2α, is Involved in EMT and Acquisition of a Stem Cell-Like Phenotype in Arsenite-Transformed Human Liver Epithelial Cells.

Microrna Expression Alteration after Arsenic Trioxide Treatment in HepG‐2 Cells

Role and Mechanism of Mir-222 in Arsenic-Transformed Cells for Inducing Tumor Growth

Oncogenic Roles and Mechanisms of Lncrna AGAP2-AS1 in Human Solid Tumors.

Induction of the Mesenchymal to Epithelial Transition by Demethylation- Activated Microrna-200C is Involved in the Anti-Migration/invasion Effects of Arsenic Trioxide on Human Breast Cancer Cells.

Arsenic Sulfide Induces Mir-4665-3p to Inhibit Gastric Cancer Cell Invasion and Migration

The Overexpression of Multidrug Resistance-Associated Proteins and Gankyrin Contribute to Arsenic Trioxide Resistance in Liver and Gastric Cancer Cells

Genomic and epigenetic characterization of the arsenic-induced oncogenic microRNA-21

miRNAs and arsenic-induced carcinogenesis

Arsenic-Induced Carcinogenesis: The Impact of miRNA Dysregulation

Targeting the miR-122/PKM2 autophagy axis relieves arsenic stress

How MicroRNAs Command the Battle against Cancer

Regulation of MicroRNA-497-Targeting AKT2 Influences Tumor Growth and Chemoresistance to Cisplatin in Lung Cancer

Multiple roles of arsenic compounds in phase separation and membraneless organelles formation determine their therapeutic efficacy in tumors

miRNA-based biomarkers, therapies, and resistance in Cancer

MicroRNA 192 Regulates Chemo-Resistance of Lung Adenocarcinoma for Gemcitabine and Cisplatin Combined Therapy by Targeting Bcl-2.

Mir-152 As a Tumor Suppressor Microrna: Target Recognition and Regulation in Cancer.